Summary of XPA c.555+8A>G splicing founder variant in 16 Pakistani and Indian XP-A patients.
<p><sup>a</sup>Neurological severity was assessed using our neurological abnormality scoring scale in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1011265#pgen.1011265.t001" target="_blank">Table 1</a>. “Unknown” indicates patients under age 10 years or with insufficient information to classify. <sup>b</sup>Number of patients classified. <sup>c</sup>Age of patients classified. <b>UDS</b>: unscheduled DNA synthesis <b>D</b><sub><b>37</b></sub>: dose that results in 37% cell survival after UVC irradiation</p> <p>(DOCX)</p>
Publication Details
- Journal
- Figshare
- Published
- 2024-12-02
- DOI
- https://doi.org/10.1371/journal.pgen.1011265.s005
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00